MARKET

IVVD

IVVD

Invivyd
NASDAQ
1.590
-0.120
-7.02%
After Hours: 1.651 +0.061 +3.82% 19:58 02/06 EST
OPEN
1.760
PREV CLOSE
1.710
HIGH
1.800
LOW
1.580
VOLUME
5.84M
TURNOVER
--
52 WEEK HIGH
3.070
52 WEEK LOW
0.4363
MARKET CAP
448.36M
P/E (TTM)
-3.3573
1D
5D
1M
3M
1Y
5Y
1D
BUZZ-U.S. STOCKS ON THE MOVE-Allurion, Rithm Capital, Medtronic
Reuters · 5d ago
BUZZ-U.S. STOCKS ON THE MOVE-Western Digital, Broadridge, WTW
Reuters · 5d ago
Analysts Offer Insights on Healthcare Companies: Invivyd (IVVD) and Pfizer (PFE)
TipRanks · 5d ago
Invivyd rises as FDA agrees with late-stage trial design for COVID-19 therapy
Seeking Alpha · 5d ago
BUZZ-U.S. STOCKS ON THE MOVE-JetBlue, VSE, Walt Disney
Reuters · 5d ago
BUZZ-Invivyd rises on late-stage trial testing COVID antibody against mRNA vaccines
Reuters · 5d ago
Invivyd Has Received and is Aligned With Advice From the FDA On LIBERTY Phase 3 Trial for VYD2311, the Company's Investigational Monoclonal Antibody to Prevent Covid-19, Versus Commercially Available mRNA COVID Vaccines
Benzinga · 5d ago
Invivyd aligns with FDA on LIBERTY Phase 3 trial of VYD2311
TipRanks · 5d ago
More
About IVVD
Invivyd, Inc. is a biopharmaceutical company. The Company’s proprietary INVYMAB platform approach combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering. INVYMAB is designed to facilitate the rapid, serial generation of new monoclonal antibodies (mAbs) to keep pace with evolving viral threats. The Company delivers antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, such as SARS-CoV-2. Its PEMGARDA (pemivibart) is the Company's first mAb to receive regulatory authorization and is designed to keep pace with SARS-CoV-2 viral evolution. PEMGARDA is used for the pre-exposure prophylaxis (prevention) of COVID-19 in adults and adolescents. Its VYD2311 is optimized for neutralization potency against SARS-CoV-2 lineages such as BA.2.86 and JN.1. The Company also has additional anti-SARS-CoV-2 mAb candidates in discovery and pre-clinical characterization.

Webull offers Invivyd Inc stock information, including NASDAQ: IVVD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IVVD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IVVD stock methods without spending real money on the virtual paper trading platform.